Home
Your Profile
Become a Member/Get Newsletter
Contact Us
Recent Updates
Current Papers
Search All Papers
Search Comments
Research News
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Tech Corner
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by
NARSAD
, the Brain and Behavior Research Fund, and was created with funding from the
U.S. National Institute of Mental Health
.
Printable version
SZGene - Gene overview of all published SZ-association studies for SLC6A3
Gene:
SLC6A3
(DAT; DAT1)
View on AlzGene
View on PDGene
Protein:
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
(dopamine transporter)
Chromosome:
5
(View:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
X
Y
MT
)
Status:
Updated 22 October 2010
1. Case-Control Studies (by ethnic group)
SZ Cases
Normal Controls
Study
Population
Source
# Polys
# Subjects
(% women)
DX
Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result
Comment
Caucasian
Alvarez, 2009
Spain
CL
2
(detail)
159
(-)
IV
-
-
290
(62%)
61.7 + 11
(-)
Negative
Bodeau-Pean, 1995
France
CL
1
(detail)
91
(32%)
IIIR
24 + 6.2
(-)
42 + 12
(-)
91
(45%)
48 + 11
(-)
Negative
Cordeiro, 2004
Brazil
CL
1
(detail)
220
(-)
IV
-
-
226
(22%)
-
Negative
Daniels, 1995
UK
CL
1
(detail)
92
(39%)
IIIR
-
56
(26-87)
84
(42%)
52
(18-95)
Negative
Hoogendoorn, 2005
Netherlands
CL
1
(detail)
208
(-)
IV
-
-
288
(-)
-
Negative
Joober, 2000
Canada
CL
1
(detail)
106
(29%)
IV
-
39.5 + 8.3
(-)
89
(-)
-
Negative
Mas, 2009
Spain
CL
14
(detail)
159
(-)
IV
-
-
373
(54%)
51.9 + 19
(-)
Negative
Meda, 2009
USA
CL
1
(detail)
31
(-)
IV
-
-
35
(-)
-
Negative
Pal, 2009
Croatia
CL
8
(detail)
103
(42%)
10
-
436 + 106
(23-74)
131
(-)
503 + 75
(30-74)
Positive
Persico, 1997
Italy
CL
1
(detail)
147
(37%)
IIIR
-
-
84
(-)
-
Trend
Prata, 2009b
Overlaps with
Prata, 2009c
CL
1
(detail)
41
(-)
IV
-
-
44
(-)
-
n.a.
Prata, 2009c
UK
CL
1
(detail)
41
(17%)
IV
-
35.2 + 11.4
(-)
44
(50%)
33.4 + 10.1
(-)
Positive
Saiz, 2009
Spain
CL
1
(detail)
288
(40%)
IV
-
363 + 124
(-)
421
(49%)
406 + 113
(-)
Positive
Szekeres, 2004
Hungary
CL
1
(detail)
75
(55%)
IV
-
-
45
(62%)
36.4 + 12.8
(-)
Negative
Talkowski, 2008
USA
CL
17
(detail)
478
(-)
IV
-
-
501
(-)
-
Positive
Talkowski, 2008
Overlaps with
Talkowski, 2008
CL
6
(detail)
328
(-)
IV
-
501
(-)
-
-
n.a.
Asian
Fujiwara, 1997
Japan
CL
1
(detail)
115
(-)
M
-
-
26
(-)
-
Negative
Huang, 2009
China
CL
6
(detail)
352
(38%)
IV
27.7 + 11.2
(-)
36.4 + 12.3
(-)
311
(35%)
38 + 10.7
(-)
Positive
Inada, 1996
Japan
CL
1
(detail)
118
(54%)
IIIR
-
59
(22-86)
117
(53%)
46
(20-80)
Negative
Jeong, 2004
Korea
CL
4
(detail)
252
(40%)
IV
-
33.2 + 8.2
(-)
271
(41%)
22.4 + 6.6
(-)
Negative
Li, 1994
China
CL
1
(detail)
105
(33%)
U
-
27.5 + 7.4
(15-51)
98
(36%)
25 + 6.9
(19-50)
Negative
Liu, 2004
Taiwan
CL
1
(detail)
79
(6%)
IV
23.5 + 8.4
(-)
29.1 + 6.2
(-)
72
(8%)
29.6 + 6.8
(-)
Negative
Other/Mixed
Galehdari, 2009
Iran
CL
1
(detail)
200
(42%)
IV
-
43.3 + 11.3
(-)
200
(-)
39.4 + 11.1
(-)
Negative
Khodayari, 2004
Iran
CL
1
(detail)
100
(0%)
IV
-
40.9 + 8
(-)
100
(0%)
45 + 5.4
(-)
Positive
Martinez, 2001
USA
CL
1
(detail)
28
(-)
IV
-
-
31
(-)
-
Negative
Semwal, 2002
India
CL
1
(detail)
536
(44%)
IV
-
22.8 + 7
(-)
936
(47%)
32.9 + 12.7
(-)
Negative
Wonodi, 2008
USA
CL
1
(detail)
190
(-)
IV
-
-
160
(-)
-
Negative
Contact us
if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
2. Family-Based Studies (by ethnic group)
Affecteds
Unaffecteds
Study
Population
# Polys
# Families
# Subjects
(% women)
DX
Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result
Comment
Caucasian
Cordeiro, 2004
Brazil
1
(detail)
49
49
(-)
IV
-
-
98
(50%)
-
Negative
Georgieva, 2002
Bulgaria
1
(detail)
178
178
(51%)
IV
23.7 + 7.1
(-)
-
356
(50%)
59.6 + 9.1
(-)
Negative
Stober, 2006
Germany
4
(detail)
82
82
(32%)
U
23 + 6.2
(-)
29.8 + 7.3
(-)
164
(50%)
-
Positive
Talkowski, 2008
Bulgaria
16
(detail)
659
659
(50%)
IV
-
-
1318
(50%)
-
Positive
Talkowski, 2008
USA
6
(detail)
150
150
(50%)
IV
-
-
300
(50%)
-
Positive
Other/Mixed
Fanous, 2004
USA
1
(detail)
197
(-)
IIIR
-
-
177
(-)
-
Negative
Maier, 1996
Germany, Israel
2
(detail)
108
-
U
-
-
-
-
Negative
Semwal, 2001
India
1
(detail)
178
179
(42%)
IV
22.1 + 6.3
(-)
-
-
-
Negative
Contact us
if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
Source:
Source of case population -> “CL” (clinic-based), “PO” (population-based), or “CO” (community-based).
# Polys:
Number of polymorphisms tested per gene and per sample.
Onset Age and Age:
Mean or median age at onset or examination, respectively.
DX:
Criteria used to determine SZ diagnosis -> "IIIR"(DSM-IIIR), "IV" (DSM-IV), "9" (ICD-9), "10" (ICD-10), "M" (Mixed), "RDC" (Research Diagnostic Criteria), "U" (Unknown).
Result:
Overall conclusion reached by authors of the original publication (“positive” usually indicates significant (P<0.05) association in at least one of the performed analyses, and “negative” indicates no evidence for significant association, while “trend” indicates results in between).
(-)
: Either no data provided or in case of overlap, data included in original study.
SZGene Recent Updates
SZGene Stats
Studies: 1727
Genes: 1008
Polymorphisms: 8788
Meta-analyses: 287
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
SRF News
SRF Comments
Text Size
Reset Text Size
Email this page
Research Participants
Collaborators
Copyright © 2005-2023 Schizophrenia Research Forum
Privacy Policy
Disclaimer
Disclosure
Copyright